<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>In a subset of <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) patients, <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e>, characterized by occurrence of anti-<z:chebi fb="0" ids="28494">cardiolipin</z:chebi> (CL) antibodies, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo>, <z:mp ids='MP_0005048'>thrombosis</z:mp> and recurrent intrauterine fetal <z:hpo ids='HP_0011420'>death</z:hpo> occurs </plain></SENT>
<SENT sid="1" pm="."><plain>Male (NZW x BXSB)F1 mice, carrying the BXSB Yaa gene, serve as a model for SLE-associated <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Using microsatellite markers in the NZW x (NZW x BXSB)F1 backcross male progeny, we mapped BXSB alleles contributing to the generation of anti-CL antibodies, platelet-binding antibodies, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>Generation of each disease character was controlled by two major independently segregating dominant alleles, i.e. those on chromosomes (Chr.) 4 and 17 for anti-CL antibodies, Chr </plain></SENT>
<SENT sid="4" pm="."><plain>8 and 17 for both anti-<z:hpo ids='HP_0003454'>platelet antibodies</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> and, to our surprise, Chr </plain></SENT>
<SENT sid="5" pm="."><plain>7 and 14 for <z:hpo ids='HP_0001658'>myocardial infarction</z:hpo>, and that a combination of the two alleles appeared to produce full expression of each character, as a complementary gene action </plain></SENT>
<SENT sid="6" pm="."><plain>The alleles on Chr </plain></SENT>
<SENT sid="7" pm="."><plain>17 linked to the above three characters were <z:hpo ids='HP_0000001'>all</z:hpo> mapped in close proximity to the H-2 complex </plain></SENT>
<SENT sid="8" pm="."><plain>Therefore, no single factor such as anti-CL antibodies can explain the pathogenesis of SLE-associated <z:e sem="disease" ids="C0085278" disease_type="Disease or Syndrome" abbrv="">antiphospholipid syndrome</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>Rather, a combination of susceptibility alleles such as described here, along with additional modifying loci, i.e. BXSB Yaa and some from NZW, characterizes unique SLE features in male (NZW x BXSB) F1 mice </plain></SENT>
<SENT sid="10" pm="."><plain>There are potentially important candidate genes which may be linked to the syndrome </plain></SENT>
</text></document>